BIOVIA Discovery Studio for Drug Discovery Hackathon 2020

Drive Discovery with the Leading Molecular Graphics Environment

BIOVIA Discovery Studio for Drug Discovery Hackathon 2020

The Drug Discovery Hackathon 2020 (DDH2020) vision and mission is to establish an “open innovation model” for in silico drug discovery against COVID-19 and will cover the various processes in drug discovery including, but not limited to, in silico screening of molecules, lead optimization and identification of druggable non-toxic targets. The targets, tools or lead molecules identified through the process of DDH2020 will be taken forward for synthesis followed by subsequent steps in a routine drug discovery program.

As an active supporter of the scientific community worldwide that is collaborating on COVID-19 solutions, Dassault Systèmes has developed BIOVIA Discovery Studio. This world-class life sciences modeling and simulation environment brings together over 30 years of peer-reviewed research and in silico technique. It provides researchers with a complete toolset for use, from target identification through lead optimization including tools for biologics design and analysis, classical simulations, structure- and fragment-based design, virtual ligand screening, as well as ADME (Absorption, Distribution, Metabolism, Excretion) and toxicity prediction.

We are extremely delighted to have Dassault Systèmes as our esteemed ‘Partner’ for our Drug Discovery Hackathon 2020,”  

Dr. Abhay JERE
Chief Innovation Officer (CIO), Innovation Cell, Ministry of HRD, Govt. of India

Register to download

Get Started